ARCHIVES

Gleevec Improves Survival Of CML In Accelerated Phase

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

Orlando Health President Mark Rohl We Opted For A Florida-Centric Strategy

January 10, 2014

Fox Retirement Marks End of Era for NCI Construction Program

October 6, 1989

Experts Concerned As Phase I Studies Reach Deeper Into Community Practice (Second story in a two-part series.)

April 2, 2010

Clinical Cancer Research Battling Threats, Frei Says

May 15, 1981

ACS Says New Tax Policy Hurts Charity Funds

April 25, 1980

ODAC Advises Approval Of Tamoxifen For Male Breast Cancer Treatment

November 27, 1992